Literature DB >> 7699552

Prepubertal gynecomastia during growth hormone therapy.

S Malozowski1, B V Stadel.   

Abstract

We report 22 cases of prepubertal gynecomastia diagnosed during growth hormone (GH) treatment. The age and dose range were 2 to 12 years and 0.18 [corrected] to 0.3 mg/kg per week, respectively. In most of the patients, gynecomastia appeared between 0.5 and 7 months after GH was started. Three boys were using drugs other than GH. This condition appears to be self-limited and benign.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7699552     DOI: 10.1016/s0022-3476(95)70372-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

1.  Prepubertal gynecomastia a rare complication of growth hormone therapy.

Authors:  Shrikrishna V Acharya; Raju A Gopal; Tushar R Bandgar; Padma S Menon; Nalini S Shah
Journal:  Indian J Pediatr       Date:  2010-02-08       Impact factor: 1.967

Review 2.  A risk-benefit assessment of growth hormone use in children.

Authors:  S L Blethen; M H MacGillivray
Journal:  Drug Saf       Date:  1997-11       Impact factor: 5.606

3.  Serum prolactin levels in a uremic child: effects of bilateral nephrectomy and kidney transplantation.

Authors:  Geneviève Rondeau; Aïcha Merouani; Véronique Phan; Cheri Deal; Pierre Robitaille
Journal:  NDT Plus       Date:  2011-07-27

4.  Influence of growth hormone treatment on radiographic indices of the spine: propensity-matched analysis.

Authors:  Yeo-Hon Yun; Soon-Sun Kwon; Youngdo Koh; Dong-Jun Kim; Jonghyun Ahn; Seung Yeol Lee
Journal:  J Orthop Surg Res       Date:  2017-09-06       Impact factor: 2.359

Review 5.  Growth hormone therapy in short-stature patients with kyphoscoliosis: a literature review.

Authors:  Mariam S Alharbi
Journal:  EFORT Open Rev       Date:  2022-03-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.